Stay updated on Amivantamab Clinical Trial in Advanced NSCLC
Sign up to get notified when there's something new on the Amivantamab Clinical Trial in Advanced NSCLC page.

Latest updates to the Amivantamab Clinical Trial in Advanced NSCLC page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page adds a unified 'Locations' section listing sites (California, Florida, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Missouri, New York, Oregon, Pennsylvania, Texas, Virginia, Ontario) and removes the prior state-specific location subsections; the 'HHS Vulnerability Disclosure' footer link is removed.SummaryDifference1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedDecember 2025 update entries were added (2025-12-04, 2025-12-05, and 2025-12), and November 2025 updates were removed (2025-11-07, 2025-11-06, and 2025-11).SummaryDifference0.1%

- Check34 days agoChange DetectedSite revision updated from v3.3.1 to v3.3.2; no observable changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedPublication section updated to state that PubMed entries are automatically filled, with a new 2025 citation (Lenz et al., JCO Glob Oncol), and the revision tag changed from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check49 days agoChange DetectedAdministrative updates include new update dates (2025-11-07, 2025-11-06, 2025-11) and removal of a funding-related notice; the substantive study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedNo significant changes detected; the page content appears unchanged.SummaryDifference0.3%

Stay in the know with updates to Amivantamab Clinical Trial in Advanced NSCLC
Enter your email address, and we'll notify you when there's something new on the Amivantamab Clinical Trial in Advanced NSCLC page.